Vnitr Lek 2017, 63(1):50-55 | DOI: 10.36290/vnl.2017.010

A contribution to the differential diagnostics of sclerosing cholangitides

Martin Blaho*, Petr Dítě, Martina Bojková, Martin Rydlo, Tomáš Kupka, Pavel Svoboda, Pavel Klvaňa, Arnošt Martínek
Gastroenterologické oddělení Interní kliniky LF OU a FN Ostrava

Sclerosing cholangitides represent a group of chronic biliary obstructive diseases which include primary sclerosing cholangitis (PSC), IgG4 associated sclerosing cholangitis (IgG4-SC) and secondary sclerosing cholangitis (SSC). The manifestations of the diseases are similar, but their asymptomatic course is also frequent. IgG4-SC belongs to the group of IgG4 associated diseases and it is the most frequently related to type 1 autoimmune pancreatitis. Diagnosing of IgG4-SC is based on typical histopathological images, shape changes revealed by diagnostic imaging, serological tests, concurrent impairment of other organs and response to therapy, where IgG4-SC responds well to treatment with corticoids, whereas the only possibility for the remaining units is endoscopic intervention or liver transplantation. Secondary sclerosing cholangitis may develop as a result of many different insults affecting the biliary tree. Among them, the most frequently described include long-lasting biliary obstruction, surgical injury of the biliary tree, and ischemic cholangitis in liver allotransplants or recurrent pancreatitis. We use serological and imaging examination in PSC diagnostics, sometimes we have to resort to liver biopsy. PSC is to a significant degree accompanied by the presence of idiopathic bowel disease, typically ulcerative colitis. As a result, PSC may lead to cirrhosis of the liver and it is a precancerous condition of several malignancies. With regard to variable locations of the biliary tree injuries concerning the aforementioned units, also certain malignancies in subhepatic landscape need to be considered in the differential diagnosis: pancreatic cancer and cholangiogenous carcinoma.

Keywords: genetic factors; IBD; IgG4 cholangitis; liver transplantation; bile duct cancer; ursodeoxycholic acid; primary sclerosing cholangitis; secondary cholangitis; sclerosing cholangitis

Received: September 14, 2016; Accepted: November 8, 2016; Published: January 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Blaho M, Dítě P, Bojková M, Rydlo M, Kupka T, Svoboda P, et al.. A contribution to the differential diagnostics of sclerosing cholangitides. Vnitr Lek. 2017;63(1):50-55. doi: 10.36290/vnl.2017.010.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lindkvist B, Benito de Valle M, Gullberg B et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010; 52(2): 571-577. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23678>. Go to original source... Go to PubMed...
    2. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125(5): 1364-1369. Go to original source... Go to PubMed...
    3. Kaplan GG, Laupland KB, Butzner D et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007; 102(5): 1042-1049. Go to original source... Go to PubMed...
    4. Tanaka A, Tazuma S, Okazaki K et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 2014; 21(1): 43-50. Dostupné z DOI: <http://dx.doi.org/10.1002/jhbp.50>. Go to original source... Go to PubMed...
    5. Zen Y, Harada K, Sasaki M et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28(9):1193-1203. Go to original source... Go to PubMed...
    6. Ghazale A, Chari ST, Zhang L et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134(3): 706-715. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2007.12.009>. Go to original source... Go to PubMed...
    7. Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology 2013; 57(6): 2390-2398. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.26232>. Go to original source... Go to PubMed...
    8. Hubers L, Doorenspleet M, Klarenbeek P et al. The IgG/IgG4 mRNA Ratio By Quantitative PCR Accurately Diagnoses IgG4-Related Disease and Predicts Treatment Response [abstract]. Arthritis Rheumatol 2015; 67(Suppl 10). Dostupné z WWW: <http://acrabstracts.org/abstract/the-iggigg4-mrna-ratio-by-quantitative-pcr-accurately-diagnoses-igg4-related-disease-and-predicts-treatment-response/>.[13.01.2017].
    9. Molodecky NA, Kareemi H, Parab R et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 2011; 53(5): 1590-1599. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.24247>. Go to original source... Go to PubMed...
    10. Porayko MK, Wiesner RH, LaRusso NF et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98(6): 1594-1602. Go to original source... Go to PubMed...
    11. Broome U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38(4): 610-615. Go to original source... Go to PubMed...
    12. Chapman R, Fevery J, Kalloo A et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51(2): 660-678. Dostupné z DOI:<http://dx.doi.org/10.1002/hep.23294>. Go to original source... Go to PubMed...
    13. Soetikno RM, Lin OS, Heidenreich PA et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endos 2002; 56(1): 48-54. Go to original source... Go to PubMed...
    14. Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38(2): 234-239. Go to original source... Go to PubMed...
    15. Wiesner RH, LaRusso NF, Dozois RR et al. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 1986; 90(2): 316-322. Go to original source... Go to PubMed...
    16. Fevery J, Henckaerts L, Van Oirbeek R et al. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study. Liver Int 2012; 32(2): 214-222. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1478-3231.2011.02575.x>. Go to original source... Go to PubMed...
    17. Verdonk RC, Dijkstra G, Haagsma EB et al. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant 2006; 6(6): 1422-1429. Go to original source... Go to PubMed...
    18. Marelli L, Xirouchakis E, Kalambokis G et al. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut 2011; 60(9): 1224-1228. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2010.235408>. Go to original source... Go to PubMed...
    19. Navaneethan U, Venkatesh PG, Mukewar S et al. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2012;10(5): 540-546. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2012.01.006>. Go to original source... Go to PubMed...
    20. Bergquist A, Ekbom A, Olsson R et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36(3): 321-327. Go to original source... Go to PubMed...
    21. Lindstrom L, Lapidus A, Ost A et al. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Dis Colon Rectum 2011; 54(11):1392-7. Dostupné z DOI: <http://dx.doi.org/10.1097/DCR.0b013e31822bbcc1>. Go to original source... Go to PubMed...
    22. Bergquist A, Lindberg G, Saarinen S et al. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 2005; 42(2): 252-256. Go to original source... Go to PubMed...
    23. Karlsen TH, Franke A, Melum E et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010; 138(3): 1102-1111. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2009.11.046>. Go to original source... Go to PubMed...
    24. Melum E, Franke A, Schramm C et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 2011; 43(1): 17-19. Dostupné z DOI: <http://dx.doi.org/10.1038/ng.728>. Go to original source... Go to PubMed...
    25. Lichtman SN, Sartor RB. Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats. Immunol Res 1991; 10(3-4): 528-531. Go to original source... Go to PubMed...
    26. O'Mahony CA, Vierling JM. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis 2006; 26(1): 3-21. Go to original source... Go to PubMed...
    27. Palmer KR, Duerden BI, Holdsworth CD. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 1980; 21(10): 851-854. Go to original source... Go to PubMed...
    28. Borchers AT, Shimoda S, Bowlus C et al. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol 2009; 31(3): 309-322. Dostupné z DOI: <http://dx.doi.org/10.1007/s00281-009-0167-2>. Go to original source... Go to PubMed...
    29. Grant AJ, Lalor PF, Hubscher SG et al. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 2001; 33(5): 1065-1072. Go to original source... Go to PubMed...
    30. Grant AJ, Lalor PF, Salmi M et al. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002; 359(9301): 150-157. Go to original source... Go to PubMed...
    31. MacCarty RL, LaRusso NF, Wiesner RH et al. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149(1): 39-44. Go to original source... Go to PubMed...
    32. Dave M, Elmunzer BJ, Dwamena BA et al. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010; 256(2): 387-396. Dostupné z DOI: <http://dx.doi.org/10.1148/radiol.10091953>. Go to original source... Go to PubMed...
    33. Kaltenthaler E, Vergel YB, Chilcott J et al. A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. Health Technol Assess 2004; 8(10; iii): 1-89. Go to original source... Go to PubMed...
    34. Burak KW, Angulo P, Lindor KD Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 2003; 98(5): 1155-1158. Go to original source... Go to PubMed...
    35. Corpechot C, El Naggar A, Poujol-Robert A et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43(5): 1118-1124. Go to original source... Go to PubMed...
    36. Wong GL. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274. Dostupné z DOI: <http://dx.doi.org/10.4254/wjh.v5.i5.264>. Go to original source... Go to PubMed...
    37. Abd El Rihim AY, Omar RF, Fathalah W et al. Role of fibroscan and APRI in detection of liver fibrosis: a systematic review and meta-analysis. Arab J Gastroenterol 2013; 14(2): 44-50. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ajg.2013.05.002>. Go to original source... Go to PubMed...
    38. Triantos CK, Koukias NM, Nikolopoulou VN et al. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther 2011; 34(8): 901-910. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2036.2011.04822.x>. Go to original source... Go to PubMed...
    39. Eaton JE, Silveira MG, Pardi DS et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol 2011; 106(9): 1638-1645. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2011.156>. Go to original source... Go to PubMed...
    40. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51(2): 237-267. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2009.04.009>. Go to original source... Go to PubMed...
    41. Hommes DW, Erkelens W, Ponsioen C et al. A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis. J Clin Gastroenterol 2008; 42(5): 522-526. Dostupné z DOI: <http://dx.doi.org/10.1097/MCG.0b013e3181662426>. Go to original source... Go to PubMed...
    42. [European Association for the Study of the Liver]. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016; 64(2): 433-485. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2015.10.006>. Go to original source... Go to PubMed...
    43. Darwish Murad S, Kim WR, Harnois DM et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143(1): 88-98.e3. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2012.04.008>. Go to original source... Go to PubMed...
    44. Nakazawa T, Naitoh I, Hayashi K et al. Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol 2013; 19(43): 7661-7670. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v19.i43.7661>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.